HEADER TRANSCRIPTION 23-MAY-17 5O3B TITLE HUMAN BRD2(BD2) MUTANT IN COMPLEX WITH AL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS THE BROMODOMAIN AND EXTRA-TERMINAL DOMAIN (BET) FAMILY CHROMATIN KEYWDS 2 BINDING PROTEIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.C.RUNCIE,K.-H.CHAN,A.CIULLI REVDAT 3 17-JAN-24 5O3B 1 REMARK REVDAT 2 16-MAY-18 5O3B 1 JRNL REVDAT 1 14-FEB-18 5O3B 0 JRNL AUTH A.C.RUNCIE,M.ZENGERLE,K.H.CHAN,A.TESTA,L.VAN BEURDEN, JRNL AUTH 2 M.G.J.BAUD,O.EPEMOLU,L.C.J.ELLIS,K.D.READ,V.COULTHARD, JRNL AUTH 3 A.BRIEN,A.CIULLI JRNL TITL OPTIMIZATION OF A "BUMP-AND-HOLE" APPROACH TO JRNL TITL 2 ALLELE-SELECTIVE BET BROMODOMAIN INHIBITION. JRNL REF CHEM SCI V. 9 2452 2018 JRNL REFN ISSN 2041-6520 JRNL PMID 29732121 JRNL DOI 10.1039/C7SC02536J REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 40702 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2002 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.0489 - 4.6981 1.00 2922 157 0.1664 0.2026 REMARK 3 2 4.6981 - 3.7296 1.00 2814 161 0.1542 0.1792 REMARK 3 3 3.7296 - 3.2583 1.00 2767 145 0.1748 0.2237 REMARK 3 4 3.2583 - 2.9605 1.00 2780 144 0.1957 0.2644 REMARK 3 5 2.9605 - 2.7483 1.00 2746 149 0.2007 0.2403 REMARK 3 6 2.7483 - 2.5863 1.00 2771 135 0.2139 0.2722 REMARK 3 7 2.5863 - 2.4568 1.00 2765 135 0.2028 0.2466 REMARK 3 8 2.4568 - 2.3499 1.00 2734 155 0.2068 0.2780 REMARK 3 9 2.3499 - 2.2594 1.00 2770 122 0.2167 0.2601 REMARK 3 10 2.2594 - 2.1814 0.99 2720 130 0.2646 0.3097 REMARK 3 11 2.1814 - 2.1132 1.00 2743 133 0.2316 0.2665 REMARK 3 12 2.1132 - 2.0528 0.99 2716 139 0.2711 0.3188 REMARK 3 13 2.0528 - 1.9988 1.00 2728 151 0.2720 0.3239 REMARK 3 14 1.9988 - 1.9500 1.00 2724 146 0.2774 0.3382 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.590 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3853 REMARK 3 ANGLE : 1.043 5205 REMARK 3 CHIRALITY : 0.042 516 REMARK 3 PLANARITY : 0.005 664 REMARK 3 DIHEDRAL : 12.417 1412 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5O3B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1200005101. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9174 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40791 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 44.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.600 REMARK 200 R MERGE (I) : 0.28270 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.80 REMARK 200 R MERGE FOR SHELL (I) : 0.96970 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4QEU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 7.5 60% PENTAERYTHRITOL REMARK 280 PROPOXYLATE (5/4 PO/OH) 0.2M IMIDAZOLE PH 8.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.03750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.94650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 61.76700 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.03750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.94650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.76700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.03750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.94650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.76700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.03750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.94650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 61.76700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 701 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 342 REMARK 465 MET A 343 REMARK 465 GLY A 344 REMARK 465 LYS A 345 REMARK 465 LEU A 346 REMARK 465 ASP A 455 REMARK 465 SER B 342 REMARK 465 MET B 343 REMARK 465 GLY B 344 REMARK 465 LYS B 345 REMARK 465 SER C 342 REMARK 465 MET C 343 REMARK 465 GLY C 344 REMARK 465 LYS C 345 REMARK 465 SER D 342 REMARK 465 MET D 343 REMARK 465 GLY D 344 REMARK 465 LYS D 345 REMARK 465 ASP D 455 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP D 407 O HOH D 601 1.93 REMARK 500 O LYS C 452 O HOH C 601 2.00 REMARK 500 OE1 GLU D 404 O HOH D 602 2.01 REMARK 500 O HOH B 696 O HOH B 715 2.03 REMARK 500 O HOH C 605 O HOH C 611 2.03 REMARK 500 O HOH C 692 O HOH C 728 2.03 REMARK 500 O HOH B 704 O HOH B 727 2.04 REMARK 500 O HOH A 742 O HOH A 743 2.05 REMARK 500 O HOH B 622 O HOH D 675 2.05 REMARK 500 O HOH A 607 O HOH A 637 2.06 REMARK 500 OD2 ASP A 434 O HOH A 601 2.10 REMARK 500 O HOH D 624 O HOH D 685 2.10 REMARK 500 O HOH C 609 O HOH C 728 2.11 REMARK 500 OE1 GLU A 404 O HOH A 602 2.11 REMARK 500 O HOH B 658 O HOH B 670 2.12 REMARK 500 O HOH B 687 O HOH B 712 2.13 REMARK 500 O HOH C 643 O HOH C 714 2.14 REMARK 500 O HOH B 655 O HOH B 724 2.14 REMARK 500 O HOH B 642 O HOH B 708 2.17 REMARK 500 O HOH A 699 O HOH A 727 2.17 REMARK 500 O HOH B 656 O HOH B 659 2.18 REMARK 500 CA SER C 379 O HOH C 618 2.19 REMARK 500 N ALA A 411 O HOH A 603 2.19 REMARK 500 O HOH C 614 O HOH C 699 2.19 REMARK 500 O HOH B 646 O HOH B 704 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 688 O HOH A 721 2455 1.91 REMARK 500 O HOH B 642 O HOH C 711 6445 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 746 DISTANCE = 6.20 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9HZ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9HZ B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9HZ C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9HZ D 501 DBREF 5O3B A 344 455 UNP P25440 BRD2_HUMAN 344 455 DBREF 5O3B B 344 455 UNP P25440 BRD2_HUMAN 344 455 DBREF 5O3B C 344 455 UNP P25440 BRD2_HUMAN 344 455 DBREF 5O3B D 344 455 UNP P25440 BRD2_HUMAN 344 455 SEQADV 5O3B SER A 342 UNP P25440 EXPRESSION TAG SEQADV 5O3B MET A 343 UNP P25440 EXPRESSION TAG SEQADV 5O3B VAL A 383 UNP P25440 LEU 383 ENGINEERED MUTATION SEQADV 5O3B SER B 342 UNP P25440 EXPRESSION TAG SEQADV 5O3B MET B 343 UNP P25440 EXPRESSION TAG SEQADV 5O3B VAL B 383 UNP P25440 LEU 383 ENGINEERED MUTATION SEQADV 5O3B SER C 342 UNP P25440 EXPRESSION TAG SEQADV 5O3B MET C 343 UNP P25440 EXPRESSION TAG SEQADV 5O3B VAL C 383 UNP P25440 LEU 383 ENGINEERED MUTATION SEQADV 5O3B SER D 342 UNP P25440 EXPRESSION TAG SEQADV 5O3B MET D 343 UNP P25440 EXPRESSION TAG SEQADV 5O3B VAL D 383 UNP P25440 LEU 383 ENGINEERED MUTATION SEQRES 1 A 114 SER MET GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN SEQRES 2 A 114 GLY ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA SEQRES 3 A 114 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA SEQRES 4 A 114 LEU GLY VAL HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO SEQRES 5 A 114 MET ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG SEQRES 6 A 114 ASP TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG SEQRES 7 A 114 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP SEQRES 8 A 114 HIS ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL SEQRES 9 A 114 PHE GLU PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 B 114 SER MET GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN SEQRES 2 B 114 GLY ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA SEQRES 3 B 114 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA SEQRES 4 B 114 LEU GLY VAL HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO SEQRES 5 B 114 MET ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG SEQRES 6 B 114 ASP TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG SEQRES 7 B 114 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP SEQRES 8 B 114 HIS ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL SEQRES 9 B 114 PHE GLU PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 C 114 SER MET GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN SEQRES 2 C 114 GLY ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA SEQRES 3 C 114 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA SEQRES 4 C 114 LEU GLY VAL HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO SEQRES 5 C 114 MET ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG SEQRES 6 C 114 ASP TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG SEQRES 7 C 114 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP SEQRES 8 C 114 HIS ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL SEQRES 9 C 114 PHE GLU PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 D 114 SER MET GLY LYS LEU SER GLU GLN LEU LYS HIS CYS ASN SEQRES 2 D 114 GLY ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA SEQRES 3 D 114 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA SEQRES 4 D 114 LEU GLY VAL HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO SEQRES 5 D 114 MET ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG SEQRES 6 D 114 ASP TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG SEQRES 7 D 114 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP SEQRES 8 D 114 HIS ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL SEQRES 9 D 114 PHE GLU PHE ARG TYR ALA LYS MET PRO ASP HET 9HZ A 501 55 HET 9HZ B 501 55 HET 9HZ C 501 55 HET 9HZ D 501 55 HETNAM 9HZ METHYL (2~{R})-2-[(4~{S})-6-(4-CHLOROPHENYL)-8-METHOXY- HETNAM 2 9HZ 1-METHYL-4~{H}-[1,2,4]TRIAZOLO[4,3-A][1, HETNAM 3 9HZ 4]BENZODIAZEPIN-4-YL]PENT-4-ENOATE FORMUL 5 9HZ 4(C24 H23 CL N4 O3) FORMUL 9 HOH *559(H2 O) HELIX 1 AA1 SER A 347 SER A 362 1 16 HELIX 2 AA2 HIS A 365 TRP A 370 1 6 HELIX 3 AA3 PRO A 371 TYR A 373 5 3 HELIX 4 AA4 ALA A 378 GLY A 382 5 5 HELIX 5 AA5 ASP A 385 ILE A 390 1 6 HELIX 6 AA6 ASP A 395 ASN A 405 1 11 HELIX 7 AA7 ASP A 410 ASN A 429 1 20 HELIX 8 AA8 HIS A 433 LYS A 452 1 20 HELIX 9 AA9 SER B 347 SER B 362 1 16 HELIX 10 AB1 HIS B 365 TRP B 370 1 6 HELIX 11 AB2 PRO B 371 TYR B 373 5 3 HELIX 12 AB3 ASP B 377 LEU B 381 5 5 HELIX 13 AB4 ASP B 385 ILE B 390 1 6 HELIX 14 AB5 ASP B 395 ASN B 405 1 11 HELIX 15 AB6 ASP B 410 ASN B 429 1 20 HELIX 16 AB7 HIS B 433 LYS B 452 1 20 HELIX 17 AB8 SER C 347 LEU C 361 1 15 HELIX 18 AB9 SER C 362 LYS C 364 5 3 HELIX 19 AC1 HIS C 365 TRP C 370 1 6 HELIX 20 AC2 PRO C 371 TYR C 373 5 3 HELIX 21 AC3 ASP C 385 ILE C 390 1 6 HELIX 22 AC4 ASP C 395 ASN C 405 1 11 HELIX 23 AC5 ASP C 410 ASN C 429 1 20 HELIX 24 AC6 HIS C 433 LYS C 452 1 20 HELIX 25 AC7 SER D 347 LEU D 361 1 15 HELIX 26 AC8 SER D 362 LYS D 364 5 3 HELIX 27 AC9 HIS D 365 TRP D 370 1 6 HELIX 28 AD1 PRO D 371 TYR D 373 5 3 HELIX 29 AD2 ALA D 378 GLY D 382 5 5 HELIX 30 AD3 ASP D 385 ILE D 390 1 6 HELIX 31 AD4 ASP D 395 ASN D 405 1 11 HELIX 32 AD5 ASP D 410 ASN D 429 1 20 HELIX 33 AD6 HIS D 433 LYS D 452 1 20 SITE 1 AC1 10 TRP A 370 PRO A 371 VAL A 376 TYR A 428 SITE 2 AC1 10 ASN A 429 HIS A 433 ASP A 434 VAL A 435 SITE 3 AC1 10 MET A 438 HOH A 645 SITE 1 AC2 15 TRP B 370 PRO B 371 VAL B 376 LEU B 381 SITE 2 AC2 15 TYR B 386 TYR B 428 ASN B 429 HIS B 433 SITE 3 AC2 15 ASP B 434 VAL B 435 MET B 438 HOH B 629 SITE 4 AC2 15 TRP C 370 9HZ C 501 HOH C 656 SITE 1 AC3 11 TRP B 370 LEU B 381 9HZ B 501 TRP C 370 SITE 2 AC3 11 PRO C 371 VAL C 376 LEU C 381 VAL C 383 SITE 3 AC3 11 ASN C 429 HIS C 433 HOH C 647 SITE 1 AC4 10 TRP D 370 PRO D 371 LEU D 381 VAL D 383 SITE 2 AC4 10 TYR D 428 ASN D 429 HIS D 433 VAL D 435 SITE 3 AC4 10 MET D 438 HOH D 628 CRYST1 88.075 101.893 123.534 90.00 90.00 90.00 I 2 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011354 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009814 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008095 0.00000